Skip to main content

GATC Signs $3.2M DNA-Sequencing Contract with Medical Research Council

NEW YORK, May 26 (GenomeWeb News) - GATC Biotech today said it has signed a €2.5-million ($3.2 million) DNA-sequencing contract with the Medical Research Council.

According to the contract, GATC will provide the MRC's 35 sites in the United Kingdom with DNA sequencing services over a period of at least three years in return for about €2.5 million.

The MRC said it selected GATC over 10 other potential DNA sequencing service providers. A key selling point for GATC was its "fully automated sequencing process that reduces the level of human intervention and error," GATC said.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.